You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Pulmonology
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.
MD, MAS
Stephanie Christenson +2 more
Learning objectives
- Understand the shared and unique disease burden in COPD with type 2 inflammation and moderate-to-severe asthma
- Identify the role of type 2 inflammation in the pathophysiology of moderate-to-severe asthma and COPD with type 2 inflammation
- Differentiate between the clinical manifestations of type 2 inflammation in moderate-to-severe asthma and COPD with type 2 inflammation using real-world patient cases
Description
Join Dr. Nicola Hanania, Dr. Stephanie Christenson, and Dr. Mario Castro as they explore the shared and unique pathophysiological features of type 2 inflammation--driven asthma and COPD and the real-world impact on patients.
Tags
MAT-GLB-2402661 - v1.0 - 05/2024
About these experts
Related resources
